Compugen Ltd

NASDAQ:CGEN   4:00:00 PM EDT
1.67
-0.03 (-1.76%)
6:41:02 PM EDT: $1.75 +0.08 (+4.78%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)156.17M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$3.95 Million
Adjusted EPS-$0.06
See more estimates
10-Day MA$1.70
50-Day MA$1.55
200-Day MA$1.69
See more pivots

Compugen Ltd Stock, NASDAQ:CGEN

Azrieli Center, 26 Harokmim Street, Holon, Tel Aviv 58858
Israel
Phone: +972.3.765.8585
Number of Employees: 74

Description

Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses on research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel.